Since elevated liver enzymes can be a concerning side effect for individuals taking GLP-1 receptor agonists, liver function should be monitored regularly
Semaglutide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriate glucagon release, and slows gastric emptying
The most recently approved type, tirzepatide [archived link], is called a dual agonist because it mimics the effects of two gut hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
The most common side effects of semaglutide include: You may be more likely to experience gastrointestinal (digestive) side effects when youre first starting the medication and right after your dose is increased
Ozempic face is not a medical term or a direct side effect of using Ozempic, GLP-1 receptor agonists, or other weight loss medications